Research Analysts’ updated eps estimates for Friday, September 15th:

Aflac (NYSE:AFL) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $92.00 price target on the stock. According to Zacks, “Aflac shares have outperformed its industry year to date. Efforts to increase agent productivity, emphasis on sale of third-sector products, pull back on sale of first-sector products, and the introduction of new products are likely to drive long-term growth. Its strong capital position enables it to buy back shares and increase dividend payouts. Its U.S segment continues to perform strongly and will continue as company has undertaken a number of growth initiatives in this business. A favorable earnings guidance against the back drop of continued challenges in its Japan business instills our confidence in the company. Also, the Zacks Consensus Estimate for 2017 and 2018 moved up 2.3% and 0.7%, respectively, in the last 60 days.”

Instinet began coverage on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY). The firm issued a reduce rating on the stock.

ANSYS (NASDAQ:ANSS) had its neutral rating reissued by analysts at Wedbush. They currently have a $129.19 price target on the stock, up from their previous price target of $114.00.

Macquarie initiated coverage on shares of Church & Dwight (NYSE:CHD). Macquarie issued a neutral rating and a $52.00 target price on the stock.

Cummins (NYSE:CMI) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $186.00 price target on the stock. According to Zacks, “Zacks Consensus Estimate for Cummins’ quarterly earnings has been going up of late. The company is developing a Class 7 heavy-duty electric truck having a 140 kWh battery pack, to cater bus and commercial truck operators. This new electric truck will help Cummins to witness a growing trend in the demand of its truck and construction products. It is also poised to benefit from its business expansions in China and acquisitions and partnerships in North America. Also, year to date, its shares have outperformed against the industry it belongs to.”

Carvana (NASDAQ:CVNA) had its neutral rating reiterated by analysts at Wedbush. The firm currently has a $18.14 price target on the stock, down from their previous price target of $20.00.

Macquarie initiated coverage on shares of Dr Pepper Snapple Group (NYSE:DPS). They issued a neutral rating and a $95.00 target price on the stock.

Macquarie started coverage on shares of Estee Lauder Companies, Inc. (The) (NYSE:EL). Macquarie issued an outperform rating and a $124.00 price target on the stock.

Roth Capital assumed coverage on shares of Eastside Distilling (NASDAQ:ESDI). Roth Capital issued a buy rating and a $7.00 target price on the stock.

General Mills (NYSE:GIS) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $62.00 target price on the stock. According to Zacks, “General Mills' consumer-focused innovation, marketing initiatives and robust restructuring savings are making up for the sluggish revenue growth. The company is currently pursuing several initiatives focused on improving operational efficiency to generate cost savings and support its key growth strategies. By fiscal 2018, the company expects to achieve cost savings through increased efficiency, reduced complexity through SKU optimization, further supply chain optimization and continued expansion of zero-based budgeting across the business, which will result in accelerated margin expansion. It is on track to achieve its cost savings target for fiscal 2018 as it forges ahead with its margin expansion efforts. However, General Mills' shares have underperformed the industry so far this year. Slowing organic volumes are overshadowing minor improvements in profit margins.”

Hamburger Hafen und Logistik AG (ETR:HHFA) had its sell rating reissued by analysts at UBS AG.

JD Sports Fashion PLC (LON:JD) had its buy rating reissued by analysts at Investec. The firm currently has a GBX 475 ($6.13) target price on the stock.

J D Wetherspoon plc (LON:JDW) had its hold rating reissued by analysts at Canaccord Genuity. The firm currently has a GBX 1,040 ($13.43) price target on the stock.

Macquarie assumed coverage on shares of Kimberly-Clark Corporation (NYSE:KMB). Macquarie issued a neutral rating and a $121.00 price target on the stock.

Macquarie began coverage on shares of Coca-Cola Company (The) (NYSE:KO). The firm issued a neutral rating and a $47.00 target price on the stock.

FBN Securities began coverage on shares of Lions Gate Entertainment Corp. (NYSE:LGF). They issued an outperform rating on the stock.

FBN Securities began coverage on shares of Lions Gate Entertainment Co. Class A Voting Shares (NASDAQ:LGF.A). They issued an outperform rating and a $37.71 price target on the stock.

Oracle Corporation (NYSE:ORCL) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Oracle's first-quarter fiscal 2018 results were impressive. The company is benefiting from significant momentum in the SaaS offerings. The company stated that it is wining market share against salesforce.com and Workday. We believe the company’s growing cloud market share will continue to drive top-line growth in the foreseeable future. Moreover, the upcoming launch of the next-generation autonomous database, which is supported by machine learning, is a key catalyst. The stock has outperformed the industry on a year-to-date basis driven by these factors. However, soft outlook for the second quarter reflects slowing cloud momentum, particualrly due to increasing competition from Microsoft Azure and Amazon Web Services. Moreover, higher investments on PaaS and IaaS will keep margins under pressure in the near term.”

Pool Corporation (NASDAQ:POOL) was upgraded by analysts at Sidoti from a neutral rating to a buy rating.

Purplebricks Group PLC (LON:PURP) had its buy rating reiterated by analysts at Investec. The firm currently has a GBX 465 ($6.01) price target on the stock.

SAF-HOLLAND (ETR:SFQ) had its neutral rating reiterated by analysts at Deutsche Bank AG.

Unite Group (NASDAQ:UTGPF) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “The Unite Group plc is a property investment company. It develops and operates student accommodation primarily in the United Kingdom. The Unite Group plc is headquartered in Bristol, the United Kingdom. “

vTv Therapeutics (NASDAQ:VTVT) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “vTv Therapeutics Inc. is a biopharmaceutical company which is engaged in the discovery and development of orally administered small molecule drug candidates to fill unmet medical needs. Its drug candidate for the treatment of Alzheimers disease includes azeliragon TTP488, which is in Phase III clinical trials; type II diabetes drug candidates include Glucokinase Activator TTP399 and GLP-1r Agonist TTP273 which completed Phase I clinical trials; products for the prevention of muscle weakness and treatment of inflammatory disorders include HPP593, HPP737 and HPP971 which is in Phase1 clinical trials. The Company’s drug discovery platform consists of TTP Translational Technology. vTv Therapeutics Inc. is headquartered in High Point, North Carolina. “

Wandisco Plc (NASDAQ:WANSF) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “WANdisco plc involved in the development and provision of collaboration software. The Company offers active data replication which enables data editing to the cloud and on-premises data centers as well as provides data migration, disaster recovery and hybrid cloud solutions. It also offers cloud services, such as Amazon S3 active migrator, Google cloud active migrator, and Fusion hybrid cloud services as well as provides software maintenance services. WANdisco plc is based in Sheffield, the United Kingdom. “

WebMD Health Corp (NASDAQ:WBMD) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $74.00 price target on the stock. According to Zacks, “WebMD announced today that is has signed an agreement to acquire Conceptis Technologies Inc., a Montreal-based provider of online and offline medical education and promotion aimed at physicians and other healthcare professionals. Conceptis has been successful in developing a strong online presence in the cardiology community and is highly respected for the depth and breadth of content contained on its flagship. With the combination of two of the leading cardiology channels on the Internet, Medscape Cardiology and www.theheart.org, WebMD is well positioned to further its lead and penetration in this high value segment of medical marketing. “

Wells Fargo & (NYSE:WFC) had its neutral rating reaffirmed by analysts at UBS AG. UBS AG currently has a $56.00 price target on the stock, down from their previous price target of $59.00.

Select Energy Services (NASDAQ:WTTR) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Select Energy Services, Inc. is a provider of water solutions to the U.S. unconventional oil and gas industry. It offers drilling and completion activities associated with hydraulic fracturing as well as complementary water-related services which support oil and gas well completion and production activities including containment, monitoring, treatment, flowback, hauling and disposal. Select Energy Services, Inc. is headquartered in Gainesville, Texas. “

Yirendai (NYSE:YRD) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Yirendai Ltd. is involved in the online consumer finance business. Yirendai Ltd. is based in Beijing, China. “

Zafgen (NASDAQ:ZFGN) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Zafgen, Inc. is a biopharmaceutical company. The Company develops therapeutics for patients suffering from obesity and obesity-related disorders. Its lead product candidate includes Beloranib, an injection that is in Phase II clinical trials for the treatment of various indications comprising obesity and hyperphagia in Prader-Willi Syndrome patients, craniopharyngioma-associated obesity, and severe obesity in the general population. Zafgen, Inc. is headquartered in Cambridge, Massachusetts. “

Zte Corp. (OTCMKTS:ZTCOY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “ZTE Corporation is engaged in providing telecom equipment and networking solutions to telecom operators. The company offers wireless communications systems, wireline switch and access equipment, optical and data communications equipment, mobile phone handsets, data card products, and telecommunications software systems. It also engages in the production of remote control switch systems, multimedia communications systems, and communications transmission systems. The company also provides technical design, development, consultation, and related services for the research, manufacture and production of mobile communications systems equipment, satellite communications, microwave communications equipment, beepers, computer hardware and software, closed-circuit TVs, microwave communications, automated signal control, computer information processing, process monitoring systems, and fire alarm systems. ZTE Corporation is based in Shenzhen, the People’s Republic of China. “

Receive News & Ratings for Aflac Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.